Cases & Deals

Share

AmbioPharm sells company to CordenPharma

August 2026

Client(s) Baipharm

Jones Day advised Baipharm, the founder and major stockholder of AmbioPharm, in the sale of the company to CordenPharma to broaden its peptide API development and manufacturing capabilities for complex peptide programs.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.